Top 50 Biotechnology Angel Investors in Asia (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jan Hammer
Angel
|
4 | China, United States, United Kingdom | Series A, Series B, Seed | Health Care, FinTech, Medical | $2.5M–$231M |
|
Garri Zmudze
Angel
|
2 | United States, Hong Kong, Estonia | Seed, Pre-Seed, Venture - Series Unknown | Biotechnology, SaaS, Software | $300k–$2.2M |
|
Paul Buchheit
Angel
|
2 | United States, Canada, India | Seed, Series A, Angel | Software, SaaS, Health Care | $100k–$14M |
|
Koki Yabu
Angel
|
2 | Japan | Angel, Pre-Seed | Content, Finance, Data Mining | $1.7M–$3M |
|
Kuldeep Rajput
Angel
|
2 | Singapore | Pre-Seed, Series A | Life Science, Biotechnology | |
|
Bingqiang Gao
Angel
|
2 | China, Hong Kong, United States | Seed, Series A, Angel | Robotics, Electronics, Manufacturing | $1.3M–$43M |
|
Tak Wai Chung
Angel
|
2 | Singapore | Seed, Angel | Food Processing, Waste Management | |
|
Olzhas Zhiyenkul
Angel
|
2 | Singapore, Kazakhstan, United Kingdom | Pre-Seed, Seed | FinTech, Lending, Software | $331k–$750k |
|
Te Ling Nai
Angel
|
2 | Singapore | Seed, Angel | Food Processing, Waste Management | |
|
Frederik Vandermarlie
Angel
|
1 | Belgium, Singapore | Seed | Medical, Legal Tech, Health Care | $2.3M–$4M |
|
Jason Zeng
Angel
|
1 | United States, China, France | Seed, Angel, Series B | Internet, Social Media, Machine Learning | $500k–$3.6M |
|
Kane Black
Angel
|
1 | Singapore | Angel | Medical, Genetics, Health Diagnostics | |
|
Talgat Ismail
Angel
|
1 | Kazakhstan, Germany, United States | Pre-Seed, Seed, Angel | Software, Financial Services, Apps | $100k–$1.6M |
|
Woyong Fund
Angel
|
1 | China | Seed, Series A | Beauty, Medical, Lifestyle | |
|
Hirofumi Miki
Angel
|
1 | Japan | Seed, Angel, Pre-Seed | Artificial Intelligence, Content, Medical | $252k–$1.1M |
|
Hidetoshi Takano
Angel
|
1 | Japan, United States | Seed, Angel, Venture - Series Unknown | Internet, Information Technology, Content | $255k–$30M |
|
Bas Godska
Angel
|
1 | United States, The Netherlands, United Kingdom | Seed, Pre-Seed, Angel | Software, Artificial Intelligence, SaaS | $90k–$2M |
|
James Mellon
Angel
|
1 | United States, United Kingdom, Israel | Series A, Seed | Biotechnology, Food and Beverage, Food Processing | $894k–$47M |
|
Feng Hu
Angel
|
1 | United States, India, Singapore | Seed, Pre-Seed, Convertible Note | Communities, Mobile Apps, CRM | $1.3M–$1.4M |
|
Roy Oron
Angel
|
1 | Israel, United States, Singapore | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Mobile | $300k–$1.5M |
|
Alice Foo
Angel
|
1 | Singapore | Pre-Seed | Recycling, Biotechnology, Waste Management | |
|
Nadav Rosenberg
Angel
|
1 | United Kingdom, France, Israel | Seed, Pre-Seed, Series A | Software, Biotechnology, Artificial Intelligence | $1.1M–$21M |
|
Mr. Xie Youbang
Angel
|
1 | China | Seed | Health Care, Biotechnology, Pharmaceutical | |
|
Mr. He Haichao
Angel
|
1 | China | Seed | Health Care, Biotechnology, Pharmaceutical | |
|
Heslin Kim
Angel
|
1 | Estonia, Georgia, Bulgaria | Seed, Angel, Pre-Seed | Blockchain, Cryptocurrency, Web3 | $1.8M–$12M |
|
Suzhou Juming
Angel
|
1 | China | Series A | Biotechnology | |
|
Hua Guoping
Angel
|
1 | China | Series A | Biotechnology, Manufacturing, Health Diagnostics | |
|
Markus Haefeli
Angel
|
1 | Hong Kong | Seed | Biotechnology | |
|
Jaynti Kanani
Angel
|
1 | India, Singapore, United States | Seed, Pre-Seed, Series A | Blockchain, Cryptocurrency, Information Technology | $1M–$40M |
|
Hiroaki Kitano
Angel
|
1 | Japan, United States | Seed, Angel | Medical, Health Care, Fitness | $2.7M–$7.1M |
|
Eric Urhane
Angel
|
1 | United States, Mexico, Singapore | Seed, Angel | Software, Health Care, Biotechnology | $1.1M–$1.9M |
|
Ron Sim
Angel
|
1 | Singapore | Series A | Beauty, Fitness, Genetics | |
|
Kenshin Fujiwara
Angel
|
1 | Japan | Seed, Series A | Artificial Intelligence, Mobile, Medical | |
|
Johannes Hille
Angel
|
1 | Singapore | Seed | Medical, Health Care, Biotechnology | |
|
Jack Wang
Angel
|
1 | Singapore | Seed | Fertility, Biotechnology, Medical Device | |
|
Yi Shuishuishan
Angel
|
1 | China | Series A | Medical, Biopharma, Health Care | |
|
Yutaka Matsuo
Angel
|
1 | Japan | Seed, Angel | Artificial Intelligence, SaaS, Robotics | |
|
Shoji Okamoto
Angel
|
1 | Japan | Seed | Lifestyle, Life Science, Service Industry | |
|
Buddhadeb Biswas
Angel
|
1 | Singapore | Seed | mHealth, Health Care, Biotechnology | |
|
Ye Huahua
Angel
|
1 | China | Seed | Medical, Health Care, Biotechnology | |
|
Mr. Zheng Xiaodong
Angel
|
1 | China | Series A, Series B | Biotechnology, Medical, Hospital | |
|
Jiang Guangce
Angel
|
1 | China | Seed | Biopharma, Biotechnology, Pharmaceutical | |
|
Joel Neoh
Angel
|
1 | Malaysia, Hong Kong, Singapore | Seed, Angel, Pre-Seed | E-Commerce, Apps, Mobile | |
|
James Yahui
Angel
|
1 | China | Series A | Software, Health Care, Biotechnology | |
|
Kamata Tomihisa
Angel
|
1 | Japan, United States | Seed, Angel | Fitness, Medical, Genetics | |
|
Matt Cutts
Angel
|
1 | United States, Canada, Mexico | Seed, Angel, Series A | SaaS, Health Care, Medical | $493k–$2.8M |
|
Sandeep Nailwal
Angel
|
1 | United States, India, Singapore | Seed, Pre-Seed, Series A | Blockchain, Cryptocurrency, Financial Services | $450k–$40M |
|
Mr Maru
Angel
|
1 | Japan | Seed | Organic, Residential, Waste Management | |
|
Yuriko Minami
Angel
|
1 | Japan | Series A, Seed, Pre-Seed | Medical, Biotechnology, SNS | $3M–$4.7M |
|
Huang Hao
Angel
|
1 | China | Angel | Medical, Biotechnology, Manufacturing | |
| Access all 50 angel investors in Asia Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.
Show more...Investment focus
- Industry: Health Care, FinTech, Medical
- Stage:Series A, Series B, Seed
- Geography: China, United States, United Kingdom
Investor stats
- Total investments: 161
- Round size: Seed $2.5M–$23M; Series A $4M–$35M; Series B $15M–$231M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- MacroLux — MacroLux Medical Technology Co., Ltd.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
- Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.
Garri is a seasoned business angel with an extensive track record in tech business and an early investor in science-intensive ventures, such as Insilico Medicine, Basepaws, Deep Longevity. Prior to founding LongeVC, he co-founded Longenesis — a medical technology startup company working towards providing a technological bridge between Healthcare institutions and the BioTech industry with an aim to help identify and unlock the hidden value of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those in need. In 2021, Garri became Director of the Board at Longevity Science Foundation — a Swiss and USA based non-profit organisation advancing human longevity by funding research and development of medical technologies to extend the healthy human lifespan.
Show more...Investment focus
- Industry: Biotechnology, SaaS, Software
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United States, Hong Kong, Estonia
Investor stats
- Total investments: 9
- Round size: Seed $300k–$2.2M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- PickMyBrain — Digital brains of real people. Ask theirs anything. Build yours, and it answers for you day and night.
- Longenesis — Promoting collaboration between biomedical institutions, patient organizations and research partners by identifying biomedical data from metadata files, by onboarding population cohorts and by engaging new patients in the research.
- Profi — The Only Comprehensive Platform for Care Delivery & Coaching. Enabling health and wellness providers deliver outstanding programs, collaborative care and member experience, all within one modern platform.
Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Series A, Angel
- Geography: United States, Canada, India
Investor stats
- Total investments: 167
- Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$14M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
- BuildForever — We build products that feel personal, magical and deeply human
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Koki Yabu is Founder, President & CEO at Mobcast inc.
Show more...Investment focus
- Industry: Content, Finance, Data Mining
- Stage:Angel, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 3
- Round size: Angel $1.7M–$3M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Mobcast Group — mobcast is a sports entertainment company that operates a mobile entertainment platform for smartphones and feature phones. It supports customers with social game and social media services. The company was founded in 2009 and is based in Tokyo, Japan. Currently, it operates as a subsidiary of mobcast Inc.
- SmartApp Japan — Smart Apps is a developer of a blockchain services application designed for smartphones. The company's application uses cryptocurrency technology to offer token issuance, initial coin offering and dApps design support, providing a launchpad for start-up blockchain-related businesses.
Founder & CEO @ Biofourmis
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Pre-Seed, Series A
- Geography: Singapore
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Bingqiang Gao is the Independent Non-Executive Director of Q Tech.
Show more...Investment focus
- Industry: Robotics, Electronics, Manufacturing
- Stage:Seed, Series A, Angel
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 32
- Round size: Seed $1.3M–$43M; Angel $1.5M–$2.8M; Series A $10M–$28M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Wuwai Zhiqu — Wuwai Zhiqu is a developer of wearable hardware for early childhood education. Through its self-developed proactive multimodal AI Agent architecture, it can record and understand children's daily life scenarios in real time.
- Xunlu Innovation — Xunlu Innovation is a cutting-edge bicycle manufacturer based in Shenzhen, China, specializing in intelligent electric cargo bikes designed to meet modern urban mobility needs.
- Orange Cat Universe — Orange Cat Universe develops smart pet hardware, including mechanical grooming products for cats.
Tak Wai CHUNG joined EQT Partners in February 2009 as a Vice President.Tak Wai holds a Bachelor of Arts degree in Molecular Biology and Biochemistry and Mathematics-Economics from Wesleyan University (High Honors, Phi Beta Kappa), and a Master of Business Administration degree from the Tuck School of Business at Dartmouth.Prior to joiningEQT Partners, Tak Wai was with Lehman Brothers for over six years. While at Private Equity in Hong Kong, he focused on making direct investments into China. Before that, he was in the Investment Banking division covering primarily telecommunications, financial institutions and natural resources in both New York and Hong Kong.Tak Wai is a member of the Mid Market Partners Investment Committee and the Greater China II Internal Investment Committee.
Show more...Investment focus
- Industry: Food Processing, Waste Management
- Stage:Seed, Angel
- Geography: Singapore
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Ento Industries — At ENTO INDUSTRIES, food waste is given a new lease of life. Our focus as a biotechnology company is to close the loop on food waste with the help of our army of Black Soldier Flies.
Olzhas Zhiyenkul
Show more...Investment focus
- Industry: FinTech, Lending, Software
- Stage:Pre-Seed, Seed
- Geography: Singapore, Kazakhstan, United Kingdom
Investor stats
- Total investments: 4
- Round size: Seed $340k–$750k; Pre-Seed $331k–$350k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- UvU Shuttle — UvU is a passenger transportation software for schools, organizations, airports and governments.Besides the software solution (client & driver apps, dispatch system) which allows to effectively manage thousands of vehicles, UvU’s value includes: 1. Long-term contracts with organisations (corporations, shopping malls, travel agencies, schools,government entities and etc) with the access to parking and promotion activities 2. Intracity transportation infrastructure: special bus-stops, bus-lanes, 3. Investment infrastructure for private individuals (including passengers)/organisations to invest into buses having good and safe returns
- Clockster — We help small and medium businesses cut HR overhead by automating payroll, attendance and more at no cost
- Kilde — Hands-off regular income with up to 11.5% returns per year. Invest in consumer and SME loans with the leading lending firms.
Te-Ling Nai is an individual investor.
Show more...Investment focus
- Industry: Food Processing, Waste Management
- Stage:Seed, Angel
- Geography: Singapore
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Ento Industries — At ENTO INDUSTRIES, food waste is given a new lease of life. Our focus as a biotechnology company is to close the loop on food waste with the help of our army of Black Soldier Flies.
Frederik Vandermarlie
Show more...Investment focus
- Industry: Medical, Legal Tech, Health Care
- Stage:Seed
- Geography: Belgium, Singapore
Investor stats
- Total investments: 2
- Round size: Seed $2.3M–$4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- X-ZELL — Early, pain-free cancer cell detection
- Henchman — Effortlessly find the clauses you’re looking for by applying our AI to your existing contracts.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jason Zeng, one of the Core Founders and Advisor Emeritus of Tencent Group. Jason founded the Group in 1999. As the Chief Operating Officer during 1999 and 2007, Jason was responsible for overseeing the Company's business lines and product portfolios and the managing the Company’s sales and marketing activities across China. Prior to Tencent, Jason worked in the Shenzhen Data Telecommunications Bureau and was familiar with the Internet and telecommunications industries in China. Since June 2007, Jason has been the Advisor Emeritus of the Company.
Show more...Investment focus
- Industry: Internet, Social Media, Machine Learning
- Stage:Seed, Angel, Series B
- Geography: United States, China, France
Investor stats
- Total investments: 10
- Round size: Seed $500k–$3.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Quivr — A new way to date. Let matchmakers do the work for you or play Cupid yourself.
- Quivr — Quivr empowers you to take control of your digital identity, making it easier to connect with a community that truly shares your passions and values.
- Locale — The Bay Area's best bakeries, restaurants and produce all in one delivery
Kane Black is the founder of Severn Capital, a Singapore-headquartered principal investment and strategic transactions firm active across London, Asia and international capital markets. He has more than 20 years of operating, investment and corporate experience across Asia and international markets, spanning principal investment, public companies, healthcare, technology and cross-border transactions. His career has included building and leading businesses across Southeast and North Asia, executing acquisitions and strategic partnerships, and working with institutional, family-office and private capital. Kane previously served as Chief Executive of London Stock Exchange-listed Ikigai Ventures Limited (LON:IKIV), where he led the company through the acquisition of Dotlines Global (LON:DOTL) and the associated reverse takeover and readmission to the London market. He remains active across London public markets through the origination and execution of acquisitions, reverse takeovers, capital raisings and other strategic transactions. Earlier in his career, Kane held senior executive roles across the medical diagnostics sector in Singapore and the wider Asia-Pacific region, including Chief Executive roles at INEX Innovate and iGene Laboratory. During this period he led expansion across regional markets, strategic partnerships and corporate development initiatives. He was named EY Singapore Entrepreneur of the Year – Biotechnology in 2022. Kane is also a Non-Executive Director of INEX Innovate, a member of the NUS Medicine International Council and the Hong Kong Biotechnology Organisation. Through Severn Capital, he focuses on principal investment and strategic transactions involving public and private companies, with particular interests in natural resources, technology, healthcare and industrial businesses. The firm also works with companies and asset owners considering access to the London and Canadian public markets, including through acquisitions and reverse takeovers.
Show more...Investment focus
- Industry: Medical, Genetics, Health Diagnostics
- Stage:Angel
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Talgat Ismail
Show more...Investment focus
- Industry: Software, Financial Services, Apps
- Stage:Pre-Seed, Seed, Angel
- Geography: Kazakhstan, Germany, United States
Investor stats
- Total investments: 8
- Round size: Pre-Seed $100k–$1.6M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Parqour — Parqour is a smart parking management solution provider that integrates any parking hardware and mobile app to create a completely contactless experience. Parqour assists in the digitization of parking operations by deploying smart parking technologies and online payment methods. As a consequence, our partners save money on operations whileincreasing customer happiness and revenue.
- Clockster — We help small and medium businesses cut HR overhead by automating payroll, attendance and more at no cost
- OneVision — OneVision Payments specializes in providing a comprehensive suite of financial services aimed at facilitating seamless payment processes for businesses. The company offers solutions for accepting payments through Visa and Mastercard, enabling direct payments to cards within Kazakhstan. Additionally, OneVision Payments supports fiscalization,recurrent payments, and offers options for partial or full paybacks. The firm also provides services for card retention, enhancing the security and convenience of financial transactions for its clients. With a focus on leveraging technology to streamline payment systems, OneVision Payments caters to the needs of businesses looking to accept online payments via websites and mobile applications.
Woyong Fund is an individual investor.
Show more...Investment focus
- Industry: Beauty, Medical, Lifestyle
- Stage:Seed, Series A
- Geography: China
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- PAM2L Biotechnologies — Boyin Bio is an innovative biomaterial research and development and application enterprise.
- May Micromarketing — May Micromarketing is a beauty short video MCN organization with a team of people, editors, editors and operations. In the logic of the Redskins, May Beauty is mainly to learn from the existing explosions, and to make original content for their own characteristics and advantages.
After JTB Co., Ltd. and CYBIRD Co., Ltd. as an initial member of Glee Co., Ltd. is responsible for business development. Currently, he is mainly engaged in venture support in the Internet area, investing in venture and venture capital, and served as management advisor for dozens of companies. Hands-on business development, growth strategy development, financing advice, HR organization design support, partner referral and Recruit Support. He is also engaged in business support for ventures in the healthcare and university venture fields. He served as Digital Health Meetup Advisor, NEDOTCP Mentor and Future 2016 Mentor.
Show more...Investment focus
- Industry: Artificial Intelligence, Content, Medical
- Stage:Seed, Angel, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 28
- Round size: Seed $252k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Go Visions — Go Visions engages in the edutainment tech for children and human resources services.
- Ai-Dounyu.com — Ai-Dounyu.com is a platform that helps organizations looking to integrate AI choose their ideal AI implementation partner for free.
- Compass — Compass is a Solve problems in the local labor market with Consultation x Technology
Joined Intelligence in 1999. Established Key Players Inc. in 2005. Consultation with more than 3,000 managers and career counseling for more than 10,000 individuals. In addition, we have invested in more than 55 outside directors, advisors and angels in Silicon Valley and Bangladesh in Japan. Over 100 lectures on careers, entrepreneurship and startups.
Show more...Investment focus
- Industry: Internet, Information Technology, Content
- Stage:Seed, Angel, Venture - Series Unknown
- Geography: Japan, United States
Investor stats
- Total investments: 42
- Round size: Seed $255k–$5.7M; Angel $493k–$30M; Venture - Series Unknown $461k–$3.8M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Kaimak — Kaymak is a recruitment platform that focuses on creating a recruitment website, planning a recruitment strategy, and managing candidates.
- D-Chain — D-Chain offers services related to IT development and production in the Web3 and Web2 fields.
- Rayout — Rayout is a business consulting company that provides creative content development, recruitment videos, and web production services.
Bas Godska is based out of Amsterdam, Noord-Holland and is the Co-Founder of Netherlands for Ukraine. Bas previously worked at LinkPizza as an Angel investor. Bas Godska attended the University of Amsterdam.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, The Netherlands, United Kingdom
Investor stats
- Total investments: 58
- Round size: Seed $300k–$2M; Angel $90k–$110k; Pre-Seed $90k–$2M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Helio AI — Automated AI-powered recruiting platform with ATS and gamified personality test. Reduce daily workload by 60% and hire top talents in a few clicks.
- Crosscheck — One structured audit record across scheduling, scoping, pre-audit, fieldwork, reporting, non-conformities, and technical review.
- JobHire.AI — JobHire.AI for job search. Your AI Career Assistant that helps you land an interview 10 times faster, match with top employers, and boost your career growth.
James Mellon is based out of San José, Islas Baleares, and is the co-founder and chairman of Juvenescence. James previously worked at Griffin Thornton as a trainee fund manager. James Mellon attended the University of Oxford.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Series A, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 35
- Round size: Seed $894k–$20M; Series A $3M–$47M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Callers AI — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share is a new Caribbean “quirky” golden rum from the islands of Barbados and Jamaica.
Feng Hu
Show more...Investment focus
- Industry: Communities, Mobile Apps, CRM
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, India, Singapore
Investor stats
- Total investments: 5
- Round size: Seed $1.3M–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Credy — Credy provides instant online loan at low interest rate. Apply now for personal loan, education loan, medical loan, credit refinancing or other loans.
- DIVE - Dating With Games — DIVE-Dating With Gaming is a trendy dating and gaming app. It offers super interesting roleplay games that break the ice and that lead to deeper and more fun experiences between matches.
- Audetemi Inc. — Audetemi makes it easy for enterprises to enable their business on mobile, and create a superior, and engaging customer experience. Audetemi One platform allows businesses to effectively engage their customers by seamlessly integrating traditional customer engagement platforms onto their smartphones.
Roy Oron is an early stage Tech/Biotech investor as well as the founder and general partner at ITI Venture Capital Partners.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Mobile
- Stage:Seed, Series A, Pre-Seed
- Geography: Israel, United States, Singapore
Investor stats
- Total investments: 22
- Round size: Seed $300k–$1.5M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- 4M Analytics — 4M Analytics' unique Technology provides owners, consulting engineers, and contractors a complete, accurate, and up-to-date subsurface-infrastructure database.
- Atlas Invest — A platform for institutional investors to invest in real estate backed bridge loans at scale with reduced risk.
- EdiTy Therapeutics — EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells. It utilizes T-cells machinery to directly deliver gene-editing agents to target cells in-vivo. Yoav Manaster established the Ness Ziona, HaMerkaz, Israel-based company in 2020.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Alice Foo is an angel investor for Alterpacks.
Show more...Investment focus
- Industry: Recycling, Biotechnology, Waste Management
- Stage:Pre-Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AlterPacks — Alterpacks - New Materials Solutions. A Singapore Management University, Institute of Innovation & Entrepreneurship, Business Innovation Generator (BIG) Incubatee.
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France, Israel
Investor stats
- Total investments: 16
- Round size: Seed $1.1M–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
- thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
- Lindus Therapeutics — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Mr. Xie Youbang founding partner of Jinwell Fund.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.
Mr. He Haichao, Chairman of Jinwell Machinery and Chairman of Jinwell Fund
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.
With deep engagement within the DLT/blockchain sector since late 2016, Heslin’s key strengths have culminated in his full engagement in accelerating the global tokenization of securities in traditional capital markets. He is a well-known KOL across the Asia Pacific having spoken at over 30 conferences championing tokenized digital securities.Operationally he has helped scale and accelerate previous blockchain businesses across over a dozen countries in the Asia Pacific region. In his previous capacities, he has led business development, sales, and strategic partnerships for both global and regional partnerships based in China, Japan, Singapore, Australia, Korea, Hong Kong, Philippines, Vietnam, Thailand, Malaysia, Indonesia, and Taiwan. To date, his work with various clients and partners has aggregated $27bn+ USD in tokenized assets.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Web3
- Stage:Seed, Angel, Pre-Seed
- Geography: Estonia, Georgia, Bulgaria
Investor stats
- Total investments: 7
- Round size: Seed $1.8M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- NeoFi — Buy, Sell, Trade and Invest in Bitcoin, Ethereum, Shiba Inu, Dogecoin, Cardano, Polygon and 100s other cryptocurrency from India's best cryptocurrency exchange.
- Crestal — Crestal offers a decentralized platform that meets the objectives of Web3 applications through modular service architecture. The Crestal blockchain monitors and scores services using a Proof of Performance (PoP) consensus process.
- Optimum — Optimum constitutes a decentralized, high-performance memory infrastructure tailored for use across various blockchains.
Suzhou Juming
Show more...Investment focus
- Industry: Biotechnology
- Stage:Series A
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Zion Pharma — Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.
Hua Guoping is based out of Jiangyin, Jiangsu and is the founder of Hualan Pharmaceutical New Materials.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Health Diagnostics
- Stage:Series A
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Boyi Biotechnology — Boyi Biotechnology is a technology-based firm that provides vital raw materials and complete solutions to biomedical customers in the in vitro diagnostic market. It focus on diagnostic microspheres, testing raw materials, and quality control products.
Markus Haefeli is Chairman of PTG Food and Regal Springs.
Show more...Investment focus
- Industry: Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Avant Meats — They focus on technology, commercial product innovation, and branding as well as intellectual property portfolio building in the area of ‘cell-based’ animal protein food products.
Jaynti Kanani - Co-Founder @ Polygon
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: India, Singapore, United States
Investor stats
- Total investments: 40
- Round size: Seed $1.2M–$7.5M; Pre-Seed $1M–$2M; Series A $18M–$40M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Fermah — Fermah can generate proofs for any instance in which ZK is used. Fermah is credibly neutral and architected to support all proof systems. This includes zkVMs, zkEVMs, Groth16, and all other proof systems. It is optimized for cheap, fast, and reliable ZK proof generation.
- Mythik — The home of Indian Mythology and Ancient History for the whole family
- NovaNet — NovaNet offers local verifiable computing and privacy protection applications, including AI, decentralized Internet of Things (DePIN), and games.
Senior Executive Vice President and CTO at Sony Group Corporation and President & CEO at Sony Computer Science Laboratories, Inc.. He attended Waseda University.
Show more...Investment focus
- Industry: Medical, Health Care, Fitness
- Stage:Seed, Angel
- Geography: Japan, United States
Investor stats
- Total investments: 8
- Round size: Seed $2.7M–$7.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GPx — GPx is a biotech company that revolutionizes remote chronic disease management with bloodless blood tests. It is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.The company was founded in 2020and is based in Boston, Massachusetts.
- AnotherBall — AnotherBall is a blockchain startup that combines entertainment and blockchain.
- SBX Corporation — AI R&D: Deep learning, Machine learning, Automation, Text mining. Development, customization and maintenance of software platforms for drug discovery and life science research.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Eric Urhane
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Angel
- Geography: United States, Mexico, Singapore
Investor stats
- Total investments: 5
- Round size: Seed $1.1M–$1.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Ron Sim
Show more...Investment focus
- Industry: Beauty, Fitness, Genetics
- Stage:Series A
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Imagene Labs — Imagene Labs Pte Ltd empowers consumers to optimise their health by providing customised wellness and lifestyle solutions tailored to their unique DNA profiles. Led by medical doctors and scientists, the company provides an entire ecosystem of genomics-based solutions ranging from wellness DNA tests, personalised lifestyle recommendations, bespokeskin serums and nutritional supplements, and mobile health apps that help people live, look and feel their best.
Kenshin Fujiwara
Show more...Investment focus
- Industry: Artificial Intelligence, Mobile, Medical
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Helpfeel — Our vision is to make saving, sharing, and exploring ideas as natural as breathing. On this journey we're humbled to be helping millions around the world from solo makers to university research labs, from gamers to pro designers, and large to small teams like ours.
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
Johannes Hille is Chief Operations Officer at X-ZELL. He attended IBS International Business School.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Jack Wang
Show more...Investment focus
- Industry: Fertility, Biotechnology, Medical Device
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hannah Life Technologies — We make Earth's best products and services for couples in their parenthood journey.
Yi Shuishuishan
Show more...Investment focus
- Industry: Medical, Biopharma, Health Care
- Stage:Series A
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Alioth — Elios focuses on the development and application of technical products for pharmaceutical process technology.
1997 Graduated from Tokyo University, Department of Electronic and Information Engineering. In 2002, he completed the doctoral program at the same graduate school. Ph.D. (Engineering) He was a researcher at the Institute of Industrial Science and Technology since the same year. After working as a visiting researcher at Stanford University in August2005, Associate Professor of Technology Management Strategy, Institute of Research, Graduate School of Engineering, University of Tokyo in 2007. Co-Representative, Associate Professor, Global Consumption Intelligence Donation Course, Department of Technology Management Strategy, Graduate School of Engineering, Tokyo University. Professor from 2019, Graduate School of Engineering, Tokyo University of Engineering, Department of Technology Management Strategy. He specializes in artificial intelligence, web mining, big data analytics. The Society of Artificial Intelligence received the Paper Award (2002), the 20th Anniversary Project Award (2006), the Field Innovation Award (2011), and the Merit Award (2013). At the Society of Artificial Intelligence, he has been a student editorial committee and an editorial committee, and vice chair/director since 2010. Chairman of Ethics from 2014 to 2018. Chairman of Japan Deep Learning Association since 2017.
Show more...Investment focus
- Industry: Artificial Intelligence, SaaS, Robotics
- Stage:Seed, Angel
- Geography: Japan
Investor stats
- Total investments: 6
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Jizai — Jizai is a provider of artificial intelligence technology, offering AI solutions, software-as-a-service products powered by AI, and robots that utilize AI capabilities for businesses across various industries. The company focuses on generative AI, large language models (LLMs), and robotics, offering customizable AI platforms and automation tools.It also engages in AI consulting and research collaborations.
- MemoriaPet — Memoria Pet operated by Next Paradigm 2 Co., Ltd. Creates full-color 3D-printed pet figurines from a single uploaded photo. Uses AI to generate 3D models, followed by full-color 3D printing.
- Tsunagari AI — Tsunagari specializes in developing and providing AI-powered consultation services tailored for local governments, aiming to enhance administrative efficiency, support citizen engagement, and streamline public service delivery.
Shoji Okamoto is the President of Mirai Works.
Show more...Investment focus
- Industry: Lifestyle, Life Science, Service Industry
- Stage:Seed
- Geography: Japan
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Monoun — Mono.un provides users with opportunities to meet authors and collaborate on tales and specializes in bringing exciting experiences full of stories of Japanese culture to the world.
- Memory Lab — Memory Lab is a research laboratory that offers AI paper analysis and development solutions.
Buddhadeb Biswas is the Founder of 22North and the President and CEO of Polaris Networks. Bud attended the University of Michigan.
Show more...Investment focus
- Industry: mHealth, Health Care, Biotechnology
- Stage:Seed
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Ye Huahua is an Angel investor.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ruier Weikang — Ruier Weikang focuses on the development and commercialization of brain scientific disease diagnostic, monitoring, and therapy products.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mr. Zheng Xiaodong is the Chairman of Tofflon.
Show more...Investment focus
- Industry: Biotechnology, Medical, Hospital
- Stage:Series A, Series B
- Geography: China
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- St Phi Therapeutics — Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.
- Hengyu Biotechnology — Hengyu Biotechnology is a CXO platform founded by a scientific research team that provides biosafety testing and related process validation.
Dr. Jiang Guangce is the chairman of Dechuan Medical Fund.
Show more...Investment focus
- Industry: Biopharma, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Renjing Biology — Renjing Biotech is committed to the research and development of innovative drugs based on messenger ribonucleic acid (mRNA).
Joel Neoh is the Founder and CEO of Fave. He attended Monash University.
Show more...Investment focus
- Industry: E-Commerce, Apps, Mobile
- Stage:Seed, Angel, Pre-Seed
- Geography: Malaysia, Hong Kong, Singapore
Investor stats
- Total investments: 9
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Ejen2u — Platform Sistem Pengurusan Ejen paling Komprehensif
- Evo — Social Commerce Software
- ULive — ULive software automates orders from recording to managing orders from Facebook comments and allowing live sellers to perform essential functions such as product listings, inventory management, payments, and analytics. Currently we have users across Malaysia, Singapore, China, Laos and US.
Zhou Yahui is the founder and Chairman of Kunlun. He previously worked at Thousand Oaks Group as a senior director and vice president. Zhou Yahui attended Tsinghua University.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- NeoCura — NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.
Dr. Kamada earned his Ph.D. at the University of Tokyo. In 1984, he pursued his journey to establish his own business that focused on information appliances and mobile software, namely ACCESS Co., Ltd.. With great success, the company entered the Tokyo Stock Exchange Mothers Market in 2001. He left ACCESS Co., Ltd. in 2011, and founded TomyK Ltd.in 2012 where he supports startups possessing revolutionary business ideas that revitalize the Japanese economy.
Show more...Investment focus
- Industry: Fitness, Medical, Genetics
- Stage:Seed, Angel
- Geography: Japan, United States
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SmarTrial — Activaid owns and operates a social data platform for patients with inflammatory bowel disease. It allows patients to support and exchange information within the patient community with the same disease; provide information necessary for new drug development and matching to clinical trials that suits them; and improve medical treatment. YasuakiHasebe founded Activaid in 2018. It has its headquarters in Tokyo in Japan.
- Genomelink — Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and leadbioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others.
- MinD in a Device — MinD in a Device Co., Ltd. is a university-launched venture that aims to port human consciousness to devices (machines and computers) in the medium to long term based on long-term research results on consciousness. As the first step toward realization, we will evolve and deepen the "generation model" considered to be the source ofconsciousness, and promote the development of next-generation AI and social implementation.
Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his
Show more...Investment focus
- Industry: SaaS, Health Care, Medical
- Stage:Seed, Angel, Series A
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 11
- Round size: Seed $493k–$2.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Meter Feeder — Easily pay for parking through MeterFeeder
Sandeep Nailwal is based out of United States and is the Co-Founder and Chief Executive Officer of Polygon. Sandeep previously worked at Scopeweaver as a Co-Founder and CEO. Sandeep Nailwal attended the Indian Institute of Management.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Singapore
Investor stats
- Total investments: 198
- Round size: Seed $1M–$9M; Pre-Seed $450k–$6M; Series A $8M–$40M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Tria — Threely is onboarding billions onto Web3 with universal identities. Threely addresses are blockchain-agnostic identities that can be used across Web3 as a profile, chain-agnostic payment endpoints, logins, zkKYCs, and more. Threely is doing the crucial work of helping the top blockchain protocols, wallets, and dApps cast a wider net to onboard abroader part of the internet to Web3.
- Self Protocol — Future-proof your organization with identity and agent infrastructure already accessible to billions of people across 180+ countries and trusted by companies like Google.
- Multiplier — Multiplier helps institutional investors research stocks and manage their portfolios. We're live with six hedge funds, and our users spend 4+ hours a day in the platform.Investors who try "nearly every tool on the market," to quote a client of ours, "wind up with an unwieldy collection of fragmented point solutions."Those who focus on building a great setup with general agents are instead "signing up for a full-time job." So we deploy a platform called Multiplier that unifies structured data, unstructured data, AI work, human work, and tacit firm knowledge in one secure, governed, customized application.Our first vertical: independent equity funds with $250M-$5B of assets. They know AI is essential for staying relevant, but they don't have the time or talent to figure out what to do about it. But once we deploy Multiplier––"We used to spend 80% of our time gathering information and 20% of our time acting on it," said one customer. "Multiplier has flipped those percentages."
Mr. Maru
Show more...Investment focus
- Industry: Organic, Residential, Waste Management
- Stage:Seed
- Geography: Japan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AlgaleX — AlgaleX is a food technology and biotechnology company that develops AI-powered algae fermentation technology to produce sustainable food ingredients, nutritional compounds, and bioproducts. The company leverages proprietary AI-driven cultivation and fermentation systems to convert underutilized food byproducts into high-value microalgae rich innutrients such as DHA, umami compounds, and other functional ingredients. Its mission is to build a circular bioeconomy by reducing food waste while providing sustainable alternatives to marine- and animal-derived ingredients.The company's core technology is Touji-24, an AI-powered algae cultivation and fermentation control system that automates and optimizes microalgae production. Using proprietary fermentation processes and food byproducts such as awamori lees, AlgaleX cultivates algae that can be used to produce Umamo, a plant-based ingredient combining seafood-like umami flavor with high concentrations of DHA. This approach reduces reliance on wild-caught fish as a source of omega-3 fatty acids while upcycling food industry byproducts into valuable nutritional ingredients.
Yuriko Minami is the Capitalist at Mirai Sozo Organization.
Show more...Investment focus
- Industry: Medical, Biotechnology, SNS
- Stage:Series A, Seed, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 6
- Round size: Series A $3M–$4.7M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- digzyme — Digzyme is a research and development platform for creating, discovering, and evaluating new enzyme-catalyzed reactions by bioinformatics.
- Varinos — Varinos is a clinical laboratory contract analysis company that is a partner of medical institutions. Varinos provides genomic testing development and contract analysis services using the latest technology, the next-generation sequencer.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
Huang Hao is the chairman of Yuanxu Fund.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Angel
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Yiweisen — Yiweisen is a research and development firm that manufactures functional natural compound raw materials.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Angel Investors in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 angel investors investing in Asia Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!